These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 34021148)
81. Tissue-Resident Memory T Cells in Skin Diseases: A Systematic Review. Emmanuel T; Mistegård J; Bregnhøj A; Johansen C; Iversen L Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445713 [TBL] [Abstract][Full Text] [Related]
82. Lung T cell response in COVID-19. Shakiba MH; Gemünd I; Beyer M; Bonaguro L Front Immunol; 2023; 14():1108716. PubMed ID: 36875071 [TBL] [Abstract][Full Text] [Related]
83. Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects. Gil-Bescós R; Ostiz A; Zalba S; Tamayo I; Bandrés E; Rojas-de-Miguel E; Redondo M; Zabalza A; Ramírez N Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36941056 [TBL] [Abstract][Full Text] [Related]
84. Immunohistochemistry patterns of SARS-CoV-2 deaths in forensic autopsies. Lupariello F; Godio L; Di Vella G Leg Med (Tokyo); 2021 Jul; 51():101894. PubMed ID: 33894671 [TBL] [Abstract][Full Text] [Related]
85. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes. Renner K; Schwittay T; Chaabane S; Gottschling J; Müller C; Tiefenböck C; Salewski JN; Winter F; Buchtler S; Balam S; Malfertheiner MV; Lubnow M; Lunz D; Graf B; Hitzenbichler F; Hanses F; Poeck H; Kreutz M; Orsó E; Burkhardt R; Niedermair T; Brochhausen C; Gessner A; Salzberger B; Mack M Nat Commun; 2021 May; 12(1):3006. PubMed ID: 34021143 [TBL] [Abstract][Full Text] [Related]
86. Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection. Choi SS; van Unen V; Zhang H; Rustagi A; Alwahabi SA; Santos AJM; Chan JE; Lam B; Solis D; Mah J; Röltgen K; Trope W; Guh-Siesel A; Lin Z; Beck A; Edwards C; Mallajosyula V; Martin BA; Dunn JCY; Shrager J; Baric RA; Pinsky B; Boyd SD; Blish CA; Davis MM; Kuo CJ Res Sq; 2023 May; ():. PubMed ID: 37205380 [TBL] [Abstract][Full Text] [Related]
87. IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques. Nelson CE; Foreman TW; Kauffman KD; Sakai S; Gould ST; Fleegle JD; Gomez F; ; Le Nouën C; Liu X; Burdette TL; Garza NL; Lafont BAP; Brooks K; Arlehamn CSL; Weiskopf D; Sette A; Hickman HD; Buchholz UJ; Johnson RF; Brenchley JM; Via LE; Barber DL bioRxiv; 2022 Sep; ():. PubMed ID: 36172119 [TBL] [Abstract][Full Text] [Related]
88. High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. Lagunas-Rangel FA; Chávez-Valencia V J Med Virol; 2020 Oct; 92(10):1789-1790. PubMed ID: 32297995 [No Abstract] [Full Text] [Related]
89. Dynamics of Influenza-induced Lung-Resident Memory T Cells, Anatomically and Functionally Distinct Lung Mesenchymal Populations, and Dampening of Acute Lung Injury by Neutrophil Transfer of Micro-RNA-223 to Lung Epithelial Cells. Ferguson KT; McQuattie-Pimentel AC; Malsin ES; Sporn PHS Am J Respir Cell Mol Biol; 2018 Sep; 59(3):397-399. PubMed ID: 29641210 [No Abstract] [Full Text] [Related]
91. Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program. Hasan F; Chiu Y; Shaw RM; Wang J; Yee C JCI Insight; 2021 May; 6(10):. PubMed ID: 34027895 [TBL] [Abstract][Full Text] [Related]
92. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cao Y; Yisimayi A; Bai Y; Huang W; Li X; Zhang Z; Yuan T; An R; Wang J; Xiao T; Du S; Ma W; Song L; Li Y; Li X; Song W; Wu J; Liu S; Li X; Zhang Y; Su B; Guo X; Wei Y; Gao C; Zhang N; Zhang Y; Dou Y; Xu X; Shi R; Lu B; Jin R; Ma Y; Qin C; Wang Y; Feng Y; Xiao J; Xie XS Cell Res; 2021 Jul; 31(7):732-741. PubMed ID: 34021265 [TBL] [Abstract][Full Text] [Related]
93. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Lowery SA; Sariol A; Perlman S Cell Host Microbe; 2021 Jul; 29(7):1052-1062. PubMed ID: 34022154 [TBL] [Abstract][Full Text] [Related]
94. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Dugan HL; Stamper CT; Li L; Changrob S; Asby NW; Halfmann PJ; Zheng NY; Huang M; Shaw DG; Cobb MS; Erickson SA; Guthmiller JJ; Stovicek O; Wang J; Winkler ES; Madariaga ML; Shanmugarajah K; Jansen MO; Amanat F; Stewart I; Utset HA; Huang J; Nelson CA; Dai YN; Hall PD; Jedrzejczak RP; Joachimiak A; Krammer F; Diamond MS; Fremont DH; Kawaoka Y; Wilson PC Immunity; 2021 Jun; 54(6):1290-1303.e7. PubMed ID: 34022127 [TBL] [Abstract][Full Text] [Related]
95. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Le Vu S; Jones G; Anna F; Rose T; Richard JB; Bernard-Stoecklin S; Goyard S; Demeret C; Helynck O; Escriou N; Gransagne M; Petres S; Robin C; Monnet V; Perrin de Facci L; Ungeheuer MN; Léon L; Guillois Y; Filleul L; Charneau P; Lévy-Bruhl D; van der Werf S; Noel H Nat Commun; 2021 May; 12(1):3025. PubMed ID: 34021152 [TBL] [Abstract][Full Text] [Related]